Leadership

Mr. Donghoon Lee is the Chief Executive Officer and President of SK Biopharmaceuticals and its U.S. subsidiaries SK Life Science, Inc. and SK Life Science Labs. His vision is to transform all three companies so that together they become a global biotech leader while generating synergy with SK Group, its affiliates, and partners. Previously, Mr. […]

Helai Mohammad, Ph.D., is Chief Scientific Officer, at SK Life Science Labs. She joined Proteovant Therapeutics, now SK Life Science Labs, in May 2021 as Vice President, Head of Biology. Helai brings more than 20 years of experience in cancer research with almost 15 years in the industry. Before joining Proteovant, Helai was at GlaxoSmithKline (GSK) […]

Dr. Corey Strickland joined SK Life Science Labs in 2021, and is the Vice President of Molecular Technology. Molecular Technology answers the biochemistry, biophysics, proteomics, and structural biology-related questions for drug discovery teams and provides research informatics/IT capabilities. Additionally, Corey plays a critical role in guiding the development of MOPED™, our platform to discover novel […]

Kiel Kim is a Vice President, Global Business Development of SK Life Science Inc. as well as the Chief Business Officer, Chief Operating Officer, and board member of SK Life Science Labs. He is responsible for executing the vision of growing SK Life Science Labs into a global biotech company. Previously, Mr. Kim was the […]

Larry J. Jolivette, Ph.D., joined SK Life Science Labs in 2021 and is the Head of the Drug Metabolism & Pharmacokinetics (DMPK) and Safety Assessment functions. With a comprehensive understanding of the drug discovery and development process, Larry plays a critical role in guiding and executing our organization’s preclinical strategy. Before joining SK Life Science […]

Winston Wu joined Proteovant Therapeutics, now SK Life Science Labs, in August 2021 as Vice President, Head of CMC. Winston has over 30 years of CMC experience in the biotech and pharmaceutical industry. Before joining the company, he spent about 16 years at Lexicon Pharmaceuticals where his most recent position was Vice President of Chemical […]